459 related articles for article (PubMed ID: 17572168)
1. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?
Reid IR; Bolland MJ; Grey AB
Bone; 2007 Sep; 41(3):318-20. PubMed ID: 17572168
[TBL] [Abstract][Full Text] [Related]
2. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
3. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?
Brown JJ; Ramalingam L; Zacharin MR
Clin Endocrinol (Oxf); 2008 Jun; 68(6):863-7. PubMed ID: 18221397
[TBL] [Abstract][Full Text] [Related]
5. Osteonecrosis of the jaw associated with bisphosphonate therapy.
Wirth SM; Lawson AP; Sutphin SD; Adams VR
Orthopedics; 2009 Dec; 32(12):900. PubMed ID: 20000241
[No Abstract] [Full Text] [Related]
6. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
7. Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid.
García Sáenz JA; López Tarruella S; García Paredes B; Rodríguez Lajusticia L; Villalobos L; Díaz Rubio E
Med Oral Patol Oral Cir Bucal; 2007 Sep; 12(5):E351-6. PubMed ID: 17767097
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate-related osteonecrosis of the jaw: a pictorial review.
Morag Y; Morag-Hezroni M; Jamadar DA; Ward BB; Jacobson JA; Zwetchkenbaum SR; Helman J
Radiographics; 2009 Nov; 29(7):1971-84. PubMed ID: 19926757
[TBL] [Abstract][Full Text] [Related]
9. Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment.
Wehrhan F; Hyckel P; Amann K; Ries J; Stockmann P; Schlegel K; Neukam F; Nkenke E
Oral Dis; 2011 May; 17(4):433-42. PubMed ID: 21366807
[TBL] [Abstract][Full Text] [Related]
10. [Osteonecrosis of the jaw and bisphophonates in oncology].
Facon T; Bensadoun RJ; Blanc JL; Confavreux C; Gourmet R; Maes JM; Penel G; Vieillard MH; Woeller A
Bull Cancer; 2008 Apr; 95(4):413-8. PubMed ID: 18495570
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate-related osteonecrosis of the jaw.
Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
[TBL] [Abstract][Full Text] [Related]
12. Complication related to bisphosphonate therapy: osteonecrosis of the jaw.
Lee J
J Infus Nurs; 2009; 32(6):330-5. PubMed ID: 19918142
[TBL] [Abstract][Full Text] [Related]
13. The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer.
Van Poznak C
Cancer Invest; 2006 Feb; 24(1):110-2. PubMed ID: 16467002
[TBL] [Abstract][Full Text] [Related]
14. A review of bisphosphonate-associated osteonecrosis of the jaws and its management.
Lam DK; Sándor GK; Holmes HI; Evans AW; Clokie CM
J Can Dent Assoc; 2007 Jun; 73(5):417-22. PubMed ID: 17555652
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?
Diel IJ; Fogelman I; Al-Nawas B; Hoffmeister B; Migliorati C; Gligorov J; Väänänen K; Pylkkänen L; Pecherstorfer M; Aapro MS
Crit Rev Oncol Hematol; 2007 Dec; 64(3):198-207. PubMed ID: 17855108
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
Siddiqi A; Payne AG; Zafar S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate osteonecrosis: a protocol for surgical management.
Markose G; Mackenzie FR; Currie WJ; Hislop WS
Br J Oral Maxillofac Surg; 2009 Jun; 47(4):294-7. PubMed ID: 19231046
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis and bisphosphonates in oral and maxillofacial surgery.
Chaudhry AN; Ruggiero SL
Oral Maxillofac Surg Clin North Am; 2007 May; 19(2):199-206, vi. PubMed ID: 18088878
[TBL] [Abstract][Full Text] [Related]
19. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
King AE; Umland EM
Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
[TBL] [Abstract][Full Text] [Related]
20. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.
Allen MR; Burr DB
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):61-70. PubMed ID: 19371816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
